Literature DB >> 29159469

[Acne inversa/hidradenitis suppurativa: An update].

R Sabat1,2, A Tsaousi3,4, J Rossbacher5, H Kurzen6, T Fadai7, U Schwichtenberg7, S Schneider-Burrus3,8, G Kokolakis3,4, K Wolk3,4.   

Abstract

Acne inversa (AI)/hidradenitis suppurativa is a chronic, recurrent, immune-mediated dermatosis characterized by deep inflammatory nodules, abscesses, fistulas, and undermined scars in skin areas bearing apocrine glands. In addition to the cutaneous manifestation, numerous AI patients show metabolic changes, spondyloarthritis, and depression. AI leads to a strong reduction in the quality of life and an impairment of the sexual life of affected individuals and often culminates in social withdrawal, stigmatization, unemployment, and suicidal thoughts. In this overview, we summarized the most important facts about AI and propose a simple algorithm for therapy.

Entities:  

Keywords:  IL-17; IL-22; Immune-mediated disease; Metabolic alterations; TNF-α

Mesh：

Substances：

Year:  2017        PMID： 29159469     DOI： 10.1007/s00105-017-4082-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  57 in total

1.  Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.

Authors:  C O Mendonça; C E M Griffiths
Journal:  Br J Dermatol       Date:  2006-05       Impact factor: 9.302

Review 2.  Immune system to brain signaling: neuropsychopharmacological implications.

Authors:  Lucile Capuron; Andrew H Miller
Journal:  Pharmacol Ther       Date:  2011-02-17       Impact factor: 12.310

Review 3.  [Hidradenitis suppurativa/acne inversa: An update].

Authors:  J Kirschke; S Hessam; F G Bechara
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

4.  Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa.

Authors:  Kerstin Wolk; Katarzyna Warszawska; Conny Hoeflich; Ellen Witte; Sylke Schneider-Burrus; Katrin Witte; Stefanie Kunz; Annette Buss; Hans Joachim Roewert; Markus Krause; Ansgar Lukowsky; Hans-Dieter Volk; Wolfram Sterry; Robert Sabat
Journal:  J Immunol       Date:  2010-12-08       Impact factor: 5.422

5.  Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa.

Authors:  K Wolk; J Wenzel; A Tsaousi; E Witte-Händel; N Babel; C Zelenak; H-D Volk; W Sterry; S Schneider-Burrus; R Sabat
Journal:  Br J Dermatol       Date:  2017-09-19       Impact factor: 9.302

6.  Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.

Authors:  Alexa B Kimball; Francisco Kerdel; David Adams; Ulrich Mrowietz; Joel M Gelfand; Robert Gniadecki; Errol P Prens; Joel Schlessinger; Christos C Zouboulis; Hessel H van der Zee; Marie Rosenfeld; Parvez Mulani; Yihua Gu; Susan Paulson; Martin Okun; Gregor B E Jemec
Journal:  Ann Intern Med       Date:  2012-12-18       Impact factor: 25.391

7.  The symptomatology of hidradenitis suppurativa in women.

Authors:  G B Jemec
Journal:  Br J Dermatol       Date:  1988-09       Impact factor: 9.302

8.  Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment.

Authors:  Joel M Gelfand; Alexa B Kimball; Eliot N Mostow; Chiun-Fang Chiou; Vaishali Patel; H Amy Xia; Bruce Freundlich; Seth R Stevens
Journal:  Value Health       Date:  2008 May-Jun       Impact factor: 5.725

9.  MMP8 Is Increased in Lesions and Blood of Acne Inversa Patients: A Potential Link to Skin Destruction and Metabolic Alterations.

Authors:  Athanasia Tsaousi; Ellen Witte; Katrin Witte; Hans-Joachim Röwert-Huber; Hans-Dieter Volk; Wolfram Sterry; Kerstin Wolk; Sylke Schneider-Burrus; Robert Sabat
Journal:  Mediators Inflamm       Date:  2016-10-23       Impact factor: 4.711

10.  Marjolin's ulcer: a preventable malignancy arising from scars.

Authors:  Nanze Yu; Xiao Long; Jorge R Lujan-Hernandez; Kazi Z Hassan; Ming Bai; Yang Wang; Xiaojun Wang; Ru Zhao
Journal:  World J Surg Oncol       Date:  2013-12-17       Impact factor: 2.754
View more
  5 in total

Review 1.  [Surgical treatment options for hidradenitis suppurativa/acne inversa].

Authors:  L Scholl; S Hessam; S Reitenbach; F G Bechara
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

Review 2.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

3.  [Psychiatric comorbidities in hidradenitis suppurativa/acne inversa].

Authors:  Paraskevi Mavrogiorgou; Georg Juckel; Andreas Reimelt; Schapoor Hessam; Lisa Scholl; Jessica Lisa Frajkur; Eggert Stockfleth; Falk G Bechara
Journal:  Hautarzt       Date:  2021-01-04       Impact factor: 0.751

4.  Secondary prevention of hidradenitis suppurativa.

Authors:  Hjalmar Kurzen; Marina Kurzen
Journal:  Dermatol Reports       Date:  2019-10-25

Review 5.  [Hidradenitis suppurativa /acne inversa-surgical options, reconstruction and combinations with drug therapies-an update].

Authors:  P Cramer; S Schneider-Burrus; M Kovács; L Scholl; M Podda; F G Bechara
Journal:  Hautarzt       Date:  2021-07-06       Impact factor: 0.751
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.